Global Circadian Rhythm Sleep Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Circadian Rhythm Sleep Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Circadian rhythm disorders are disruptions in a patient's internal clock that regulates a variety of biological processes, which makes it difficult to follow normal sleep patterns. The circadian rhythm disorders includeDelayed sleep-wake phase, Advanced sleep-wake phase, Irregular sleep-wake rhythm, Non-24-hour sleep-wake rhythm, Shift work, Jet lag. The most common treatments for circadian rhythm disorders are healthy lifestyle changes, bright light therapy, and melatonin. It is aim to reset people's sleep-wake rhythm to align with the environment.
Circadian Rhythm Sleep Treatment report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Circadian Rhythm Sleep Treatment market is projected to reach US$ 1224.8 million in 2034, increasing from US$ 683.3 million in 2022, with the CAGR of 8.1% during the period of 2024 to 2034. Demand from Delayed Sleep Phase Syndrome (DSPS) and Advanced Sleep Phase Syndrome (ASPS) are the major drivers for the industry.
Global key players of circadian rhythm sleep treatment include Takeda Pharmaceutical, NBTY, Nature Made (Pharmavite) and Vicks (Procter & Gamble), etc. The top four players hold a share over 40%. In terms of product type, drug therapy is the largest segment, occupied for a share of approximately 80%, and in terms of application, delayed sleep phase syndrome has a share about 50%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Circadian Rhythm Sleep Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Koninklijke Philips
Luminette
Sleepace
PEGASI
Teva Pharmaceuticals
Takeda Pharmaceutical
NBTY
Vicks (Procter & Gamble)
Natrol
Nature Made (Pharmavite)
Jameison
GNC
By-Health
Segment by Type
Drug Therapy
Light Therapy
Delayed Sleep Phase Syndrome (DSPS)
Advanced Sleep Phase Syndrome (ASPS)
Irregular Sleep-Wake Disorder (ISWD)
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Circadian Rhythm Sleep Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Circadian Rhythm Sleep Treatment introduction, etc. Circadian Rhythm Sleep Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Circadian Rhythm Sleep Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Circadian Rhythm Sleep Treatment report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Circadian Rhythm Sleep Treatment market is projected to reach US$ 1224.8 million in 2034, increasing from US$ 683.3 million in 2022, with the CAGR of 8.1% during the period of 2024 to 2034. Demand from Delayed Sleep Phase Syndrome (DSPS) and Advanced Sleep Phase Syndrome (ASPS) are the major drivers for the industry.
Global key players of circadian rhythm sleep treatment include Takeda Pharmaceutical, NBTY, Nature Made (Pharmavite) and Vicks (Procter & Gamble), etc. The top four players hold a share over 40%. In terms of product type, drug therapy is the largest segment, occupied for a share of approximately 80%, and in terms of application, delayed sleep phase syndrome has a share about 50%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Circadian Rhythm Sleep Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Koninklijke Philips
Luminette
Sleepace
PEGASI
Teva Pharmaceuticals
Takeda Pharmaceutical
NBTY
Vicks (Procter & Gamble)
Natrol
Nature Made (Pharmavite)
Jameison
GNC
By-Health
Segment by Type
Drug Therapy
Light Therapy
Segment by Application
Delayed Sleep Phase Syndrome (DSPS)
Advanced Sleep Phase Syndrome (ASPS)
Irregular Sleep-Wake Disorder (ISWD)
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Circadian Rhythm Sleep Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Circadian Rhythm Sleep Treatment introduction, etc. Circadian Rhythm Sleep Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Circadian Rhythm Sleep Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices